Alfredo Carrato Selected Research

Alfredo Carrato Research Topics

Disease

68	Neoplasms (Cancer) 01/2024 - 01/2002
37	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 08/2005
29	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2002
18	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2002
17	Adenocarcinoma 05/2024 - 08/2005
8	Carcinoma (Carcinomatosis) 01/2022 - 06/2007
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2008
7	Carcinogenesis 01/2021 - 07/2009
7	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2005
6	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2009
5	Neutropenia 02/2024 - 11/2004
5	Breast Neoplasms (Breast Cancer) 03/2023 - 06/2007
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 09/2011
5	Chronic Pancreatitis 01/2022 - 03/2011
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2005
4	Diarrhea 04/2013 - 03/2005
2	Thrombocytopenia (Thrombopenia) 02/2024 - 04/2013
2	COVID-19 03/2023 - 01/2022
2	Pain (Aches) 01/2021 - 01/2021
2	Circulating Neoplastic Cells 01/2021 - 10/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2011
2	Hemorrhage 01/2019 - 07/2016
2	Anemia 07/2016 - 04/2013
2	Weight Loss (Weight Reduction) 06/2015 - 11/2004
2	Stomatitis 04/2013 - 09/2007
2	Hand-Foot Syndrome 04/2013 - 09/2007
2	Disease Progression 04/2013 - 06/2011
2	Febrile Neutropenia 04/2013 - 07/2009
2	Fatigue 04/2013 - 05/2011
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2011 - 03/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 02/2009 - 09/2006
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2009 - 11/2004
2	Rectal Neoplasms (Rectal Cancer) 07/2008 - 02/2008
1	Breakthrough Infections 03/2023

Drug/Important Bio-Agent (IBA)

17	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 06/2004
16	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 10/2002
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2008
12	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2004
9	Leucovorin (Folinic Acid)FDA Link 02/2024 - 03/2005
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2007
7	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 11/2004
7	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 08/2006
7	erucylphosphocholineIBA 11/2012 - 01/2002
6	Gemcitabine FDA Link 02/2024 - 06/2011
6	Messenger RNA (mRNA)IBA 03/2023 - 06/2007
5	TrihalomethanesIBA 01/2022 - 01/2007
5	Drinking WaterIBA 01/2022 - 01/2007
5	Capecitabine (Xeloda)FDA Link 01/2022 - 06/2005
5	ORALIT (ORS)IBA 01/2019 - 04/2007
5	Sunitinib (Sutent)FDA Link 01/2017 - 06/2011
5	CarcinogensIBA 04/2012 - 07/2006
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 10/2006
4	SmokeIBA 01/2020 - 07/2006
4	Bevacizumab (Avastin)FDA Link 01/2019 - 02/2008
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2017 - 03/2011
4	AminesIBA 04/2012 - 07/2007
3	130-nm albumin-bound paclitaxelIBA 02/2024 - 01/2015
3	LigandsIBA 01/2024 - 10/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 07/2009
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2011
3	EnzymesIBA 01/2021 - 02/2009
3	Phosphotransferases (Kinase)IBA 07/2020 - 03/2017
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2009
3	Transforming Growth Factor-beta Type I ReceptorIBA 11/2009 - 02/2009
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2008 - 11/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 10/2006
2	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2021
2	Genetic Markers (Genetic Marker)IBA 01/2023 - 10/2014
2	CollagenIBA 01/2023 - 01/2019
2	cabozantinibIBA 11/2022 - 06/2020
2	MicroRNAs (MicroRNA)IBA 04/2021 - 03/2019
2	Cytotoxins (Cytolysins)IBA 03/2021 - 03/2011
2	Tyrosine (L-Tyrosine)FDA Link 07/2020 - 04/2019
2	Formaldehyde (Formol)FDA Link 01/2020 - 08/2006
2	ParaffinIBA 01/2020 - 08/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2015
2	Panitumumab (Vectibix)FDA Link 01/2019 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2018 - 01/2018
2	nintedanibIBA 03/2017 - 11/2014
2	Codon (Codons)IBA 12/2015 - 08/2007
2	discoidin-binding polysaccharideIBA 08/2013 - 11/2010
2	SolventsIBA 10/2010 - 01/2002
2	raltitrexed (D 1694)IBA 08/2009 - 10/2008
2	XELOXIBA 05/2009 - 09/2007
2	Epirubicin (Ellence)FDA LinkGeneric 01/2009 - 11/2004
1	peptidoglycan recognition proteinIBA 05/2024
1	RutheniumIBA 01/2024
1	Immunoglobulin G (IgG)IBA 03/2023
1	2019-nCoV Vaccine mRNA-1273IBA 03/2023
1	COVID-19 VaccinesIBA 03/2023
1	Neutralizing AntibodiesIBA 03/2023
1	Cyclin-Dependent Kinase 4IBA 03/2023
1	Culture MediaIBA 01/2023

Therapy/Procedure

27	Therapeutics 01/2022 - 12/2005
23	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
4	Immunotherapy 01/2022 - 08/2019
4	Radiotherapy 01/2011 - 12/2005
3	Adjuvant Chemotherapy 01/2022 - 07/2008
3	Chemoradiotherapy 01/2018 - 07/2008
2	Gastrectomy 01/2022 - 07/2016